Emergent Biosolutions Inc

EBS 
(NYSE) 
 
$ 60,74 <%= Resources.Global.txtDown %>
Opdateret 19-10-2018
Ændring % -1,56% Fald i aktiekurs
Ændring -0,96 Fald i aktiekurs
Volume 77.995
Høj $ 63,05
Lav $ 60,42
Åben $ 62,00
ISIN
Seneste luk $ 61,70
# af aktier 50,02M
Markedsværdi 3.038,21M USD
I dag

Market closed
Emergent Biosolutions Inc
Markedet er lukket, åbner klokken 15:30
 
Kursudvikling Seneste 1 uge 1 måned 3 mdr 6 mdr 1 år
 
  60,74 0,5% Stigning i aktiekurs -7,9% Fald i aktiekurs 11,9% Stigning i aktiekurs 12,0% Stigning i aktiekurs 49,7% Stigning i aktiekurs
Powered by TradingView

Nyheder om Emergent Biosolutions Inc

  • Dansk
  • Engelsk
  • Fondsbørsmeddelelser

Firmaprofil

Emergent BioSolutions Inc is a global biotechnology company that offers biopharmaceutical products to healthcare providers and governments. The company has two operating divisions: biodefense and biosciences. Its specialty biodefense division focuses on countermeasures that address public health threats. The U.S. government is the primary purchaser of these products and often provides substantial funding for their development. Emergent's biosciences business is primarily focused on hematology and oncology therapeutics, with a secondary focus on transplantation, infectious disease, and autoimmunity.

Copyright Berlingske Media 2018  Handelsbetingelser  |  Cookiedeklaration  |  Cookie- og Privatlivspolitik  |  Ophavsret og vilkår
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
22. oktober 2018 13:04:07
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20181021.1 - EUROWEB6 - 2018-10-22 13:04:07 - 2018-10-22 13:04:07 - 1 - Website: OKAY